<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01020656</url>
  </required_header>
  <id_info>
    <org_study_id>MARIE02</org_study_id>
    <nct_id>NCT01020656</nct_id>
  </id_info>
  <brief_title>Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery</brief_title>
  <official_title>Maintenance of Anticoagulant and Antiplatelet Agents for Patients Undergoing Vitreoretinal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: To establish the prevalence of anticoagulant, aspirin, and clopidogrel use in
      patients undergoing vitreoretinal surgery, and to compare the outcome of peribulbar
      anesthesia between users and non-users.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <number_of_groups>7</number_of_groups>
  <enrollment type="Actual">206</enrollment>
  <condition>Retinal Detachment</condition>
  <arm_group>
    <arm_group_label>group 1</arm_group_label>
    <description>patients with no anticoagulants used as the control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 2</arm_group_label>
    <description>patients treated with anticoagulant therapy (warfarin, fluindone, acenocoumarol)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 3</arm_group_label>
    <description>patients treated with aspirin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 4</arm_group_label>
    <description>patients treated with clopidogrel therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 5</arm_group_label>
    <description>patients treated with both anticoagulant and aspirin medications</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 6</arm_group_label>
    <description>patients treated with both anticoagulant and clopidogrel medications</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 7</arm_group_label>
    <description>patients treated with both aspirin and clopidogrel medications</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        We analyzed the chart of 239 eyes (206 patients) which underwent posterior segment surgery
        with peribulbar anesthesia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Take or no anticoagulant treatment before surgery,

          -  Vitreoretinal surgery

        Exclusion Criteria:none

          -  No surgery

          -  Anesthetic complication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ophthalmology Unit CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <state>Burgundy</state>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2009</study_first_submitted>
  <study_first_submitted_qc>November 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2009</study_first_posted>
  <last_update_submitted>November 24, 2009</last_update_submitted>
  <last_update_submitted_qc>November 24, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2009</last_update_posted>
  <responsible_party>
    <name_title>Professor Catherine Creuzot-Garcher</name_title>
    <organization>Centre Hospitalier Universitaire Dijon</organization>
  </responsible_party>
  <keyword>anticoagulant agents</keyword>
  <keyword>antiplatelet agents</keyword>
  <keyword>vitreoretinal surgery</keyword>
  <keyword>Patients suffered from retinal detachment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Detachment</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anticoagulants</mesh_term>
    <mesh_term>Platelet Aggregation Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

